Lung cancer remains one of the leading causes of death worldwide, pressing the critical need for early and accurate discovery to ameliorate patient survival rates. This exploration investigates the effectiveness of Convolutional Neural Networks (CNNs) in relating lung cancer through medical imaging, particularly reckoned Tomography (CT) reviews. We examine how the armature of CNNs is innately designed to reuse image data and excerpt key features essential for dependable opinion. The training methodology for CNNs in this environment is developed, with a focus on data medication and crucial performance evaluation criteria similar as delicacy, perceptivity, and particularity. Our examination of being exploration underscores the promising eventuality of CNNs in lung cancer discovery, with reported rigor surpassing 90 in certain examinations.